Organisation paid for research Program year 2025 Source: CMS Open Payments

Optima Research

Neither a doctor nor a teaching hospital

Research payments

$133,763

7 payments

Through program year 2025, Optima Research is reported as receiving $133,763 in research payments, across 7 payments.

By program year

3 rows

Year	Kind	Amount	Payments
2025	Research	$32,252	1
2024	Research	$92,062	5
2023	Research	$9,448	1

Breakdown

Who paid Research payments · program years 2023–2025

Amgen Inc. $133,763 7 payments

Studies the money was for Research payments · program years 2023–2025

CORE Ph3 Prurigo Nodularis #1 $69,670 3 payments
A Phase 3, 52-Week, Multicenter, Randomized, Placebo-controlled, Double-blind Study to Assess the Efficacy, Safety, and Tolerability of Rocatinlimab in Adult Subjects With Prurigo Nodularis Who Are Inadequately Controlled on Topical Therapies or Not Eligible for Topical Therapies $32,252 1 payment
IGNITE P3 AD Adult Monotherapy Study 1 $15,692 1 payment
P3 AD Adult Monotherapy Study 1 $9,448 1 payment
ASTRO P3 AD Adolescent Mono $6,700 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.